- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MR, PET pick best biopsy sites for malignant gliomas
Clinicians can now choose from several MR and PET imaging strategies to identify a brain malignancy's most anaplastic area, according to German researchers.
Clinicians can now choose from several MR and PET imaging strategies to identify a brain malignancy's most anaplastic area, according to German researchers.
Dr. Marc-Andre Weber and colleagues from the German Cancer Research Center and nuclear medicine and radiology departments at the University of Heidelberg examined six approaches performed on 23 patients with gliomas. They found that the methods that single out areas of greatest microcirculation (dynamic contrast-enhanced MRI) and cell proliferation (MR spectroscopy or FLT-PET) are the ones best suited for marking the hot spot and enabling optimal grading of malignant gliomas.
The study was presented at the 2007 International Society for Magnetic Resonance in Medicine meeting.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
